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Autonomic conﬂict exacerbates long QT associated ventricular arrhythmias
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A B S T R A C T
This study tested the hypothesis that concomitant sympathetic and parasympathetic stimulation (“autonomic
conﬂict”) may act as a trigger for arrhythmias in long QT syndrome (LQTS). Studies were performed in isolated
innervated rabbit hearts treated with cloﬁlium (100 nmol/L); a potassium channel blocker. The inﬂuence of
vagus nerve stimulation (VNS) on spontaneous ventricular arrhythmias was assessed in the absence/presence of
sustained noradrenaline perfusion (100 nmol/L) and with sudden adrenergic stress (injections of noradrenaline
into the perfusion line). Hearts were instrumented for a pseudo-electrocardiogram and monophasic action po-
tential recordings. VNS, which slows heart rate, was associated with a stimulation frequency-dependent in-
cidence of spontaneous early after-depolarisations (EADs) and ventricular tachycardia (VT), best predicted by
the duration of the electrocardiographic T-wave and by triangulation of the ventricular action potential. In the
presence of sustained (steady-state) noradrenaline perfusion, the incidence of EADs and VT with VNS was de-
creased from 73/55% to 45/27%, respectively. However, sudden adrenergic stress, imposed during periods of
sustained VNS, was associated with a transient increase in the incidence of severity of observed arrhythmias, as
indicated by an increase in the average arrhythmias score (1.6 ± 0.4 vs. 2.1 ± 0.7, p= .01). Analysis of
electrophysiological parameters suggests that sudden adrenergic stress is associated with a transient prolonga-
tion, and increased triangulation, of the ventricular action potential, which may predispose to triggered activity.
This study demonstrates that autonomic conﬂict is a pro-arrhythmic stimulus in LQTS. However, combined
adrenergic and parasympathetic stimulation has a complex relationship with arrhythmogenicity, with diﬀer-
ences in the eﬀects of steady-state adrenergic activation vs. sudden adrenergic stress.
1. Introduction
Malignant ventricular arrhythmias (e.g. torsades de pointes - TdP)
are the primary cause of syncope and premature death in patients with
abnormal prolongation of the electrocardiographic QT interval. Despite
extensive research, the role of the autonomic nervous system in long QT
syndrome (LQTS) associated arrhythmogenesis is imperfectly under-
stood. The conventional textbook picture of the cardiac autonomic
control suggests the two branches of the autonomic nervous system
exert reciprocal actions on the heart, such as in the baroreceptor reﬂex.
In reality, this represents an over-simpliﬁcation of a system in which
simultaneous and synchronous activation often occurs [1–3]. For ex-
ample, during cold-water immersion, activation of the para-
sympathetically mediated mammalian diving reﬂex and sympathetic/
adrenergically driven cold-water shock response occurs simultaneously
[1–3].
Cold-water submersion (head under) is known to be a trigger for
supraventricular and ventricular arrhythmias in young, seemingly
healthy people, who do not exhibit evidence of arrhythmias at rest
[3–7]. These arrhythmic events are not commonly observed in the same
individuals during head out cold-water immersions (sympathetic sti-
mulation, no parasympathetic stimulations), or during facial immer-
sion, with breath-hold, which activates the parasympathetic diving
reﬂex and not the cold-shock (sympathetic) response. This suggests that
simultaneous autonomic activation, as in whole-body cold-water sub-
mersion, might be an arrhythmogenic stimulus, and is supported by
other anecdotal observations [1], but has never been tested experi-
mentally. We recently hypothesised that the sudden and simultaneous
sympathetic and parasympathetic activity, termed ‘autonomic conﬂict’,
may be a cause of arrhythmias associated with cold-water submersion
and more generally in situations where autonomic co-activation occurs
in conjunction with existing predisposing factors [3].
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Post-mortem analysis using DNA sequencing has revealed that
nearly 30% of the victims of seemingly unexplained drowning have
cardiac ion channel mutations [8]. Moreover, a strong association be-
tween swimming and arrhythmias/sudden cardiac death has been
shown in children with heritable LQTS and swimming is recognised as a
gene-speciﬁc trigger for TdP in patients with congenital LQTS type 1
[9–12]. Could this represent something more than a simple increase in
adrenergic tone? Similarly, patients with LQTS type 2 generally die
during times of sudden stress, such as when awoken by an alarm clock,
suggesting that it is sympathetic activation during periods of high
parasympathetic tone that triggers TdP [10,13]. Evidence from 24-hour
electrocardiogram recordings in patients with acquired LQTS indicates
that while prevailing rates are relatively slow, there is a signiﬁcant
increase in heart rate in the minutes preceding electrical instability and
TdP [14]. Therefore, we propose that the sequence and timing of au-
tonomic activation plays a critical role in the induction of LQTS asso-
ciated arrhythmias. In this study, we examined the role of autonomic
conﬂict as a trigger for ventricular arrhythmias in conditions of ac-
quired (type 2) LQTS. We hypothesised that concomitant sympathetic
and parasympathetic stimulation would act as a trigger for LQTS as-
sociated arrhythmogenesis.
2. Methods
2.1. Animal welfare
All procedures were undertaken in accordance with ethical guide-
lines set out by the UK Animals (Scientiﬁc Procedures) Act 1986 and
Directive 2010/63/EU of the European Parliament on the protection of
animals used for scientiﬁc purposes. Studies conformed the Guide for
the Care and Use of Laboratory Animals published by the U.S. National
Institutes of Health under assurance number A5634-01. Studies were
approved by local ethics review at King's College London.
2.2. Isolated innervated rabbit heart
All studies utilised the isolated innervated rabbit heart as described
by Ng et al., with minor modiﬁcations [10]. Experiments were per-
formed in New Zealand White Rabbits (2.5–4.5 kg). Animals were pre-
sedated using a mixture of ketamine (Ketaset, 10mg/kg, Fort Dodge,
UK), medetomidine hydrochloride (Sedator, 0.2 mg/kg, Dechra, UK)
and butorphanol (Torbugesic, 0.05mg/kg, Fort Dodge, UK) (i.m.).
Anaesthesia was induced and maintained using propofol (5 mg as re-
quired, Rapinovet, Schering-Plough Animal Health, UK), with con-
comitant heparin (1000 units, Multiparin, UK). Animals were intubated
and ventilated at 60 breaths per minute of room air. The major blood
vessels leading to and from the thorax were ligated and cut. Animals
were killed by an overdose of sodium pentobarbitone solution (160mg/
kg i.v.). The descending aorta was cannulated and the preparation ex-
cised from C1-T12 (on ice). Hearts were retrogradely perfused with an
oxygenated Krebs-Hensleit buﬀer, containing (in mM): NaCl 114, KCl 4,
CaCl 1.8, NaHCO3 24, MgSO4 1, NaH2PO4 1.1, glucose 11.0 and sodium
pyruvate 1.0. Perfusion rate was set to give an aortic pressure of
70–80mmHg. The right vagus nerve was isolated from the surrounding
tissues and placed on silver bipolar stimulating electrodes connected to
a constant voltage stimulator (DS2A, Digitimer, UK).
2.3. Experimental protocols
All hearts were instrumented for recording of a pseudo bipolar
electrocardiogram (low pass= 100 Hz, high pass= 0.3 Hz,
sampling=1KHz) and monophasic action potential from the left ven-
tricular free wall (low pass= 100 Hz, high pass= 0.3 Hz,
sampling=1 kHz). Hearts were perfused with cloﬁlium tosylate
(100 nmol/L in DMSO) for 20-min prior to the commencement of the
experimental protocols and throughout the study. 100 nmol/L cloﬁlium
was suﬃcient to cause substantive QT prolongation without AV-block,
which can occur with higher concentrations of class III anti-arrhythmic
agents.
2.3.1. Protocol 1 (sustained noradrenaline)
Cardiac responses to VNS were assessed at 2, 5, 10 and 20 Hz sti-
mulation [pulse width=1ms, amplitude=10 V, duration=2min per
frequency] in the absence and presence of 100 nmol/L noradrenaline
(+50 μM ascorbate). This represents a submaximal concentration in the
rabbit heart and produces a marked and sustained chronotropic and
electrophysiological action. Noradrenaline was perfused for a minimum
of 10-min prior to nerve stimulation.
2.3.2. Protocol 2 (bolus noradrenaline)
Noradrenaline (0.1 mL of 1mM stock) was injected directly into the
bubble trap of the perfusion apparatus at intrinsic heart rates and fol-
lowing 2-min of VNS at 5 and 10 Hz. Hearts were allowed to recover for
10-min between injections.
2.4. Blinding and randomisation
To reduced inter-operator variability, studies were conducted and
analysed by a single experimenter. The sequence of experimental pro-
tocols and order of stimulations in Protocols 1 and 2 were randomised
prior to the study. The nature of the paired study design prevented
blinding of the experimenter to the study protocols.
2.5. Data analysis
Experiments were ranked per the severity of observed arrhythmias,
using a predeﬁned arrhythmias score (no arrhythmias= 1, early
afterdepolarisations (EADs)= 2, ventricular tachycardia (VT)= 3,
sustained VT (> 20 s) or ventricular ﬁbrillation=4). Note that this is a
simple hierarchical scoring system, in which the absolute score at each
level is not a true quantiﬁcation of arrhythmias severity. Curtis and
Walker have previously shown the validity of such hierarchical systems
for use in arrhythmias quantiﬁcation [15]. EADs were assessed ﬁrst in
monophasic action potential recordings and then conﬁrmed in ECG
recordings - evidenced by an R-T ectopic in the latter and a premature
beat occurring before repolarisation of the preceding action potential in
MAP recordings. Because TdP can present monomorphic or poly-
morphic patterns in ECG recordings from the same subject, depending
on the relative angle of the recording electrode, presented values are
the number of episodes of VT. In most cases, ECG and monophasic
action potential parameters were assessed from 10-beat averages of
normally conducted beats. Monophasic action potential duration was
assessed at 90% repolarisation (MAPD90). Action potential triangula-
tion was calculated as MAPD90-MAPD30.
2.6. Statistics
Arrhythmias scores were compared by Wilcoxon's matched-groups
signed rank-sum tests. For electrophysiological parameters, parametric
statistical analyses were applied on the basis that the distribution of the
QT interval is Gaussian and on the assumption that other electrogram
parameters and related measures (e.g. action potential triangulation)
are similarly distributed. Statistical comparisons were made using
paired Student's t-tests and repeated measures one or two-way ANOVA
with Sidak's post-hoc tests, as appropriate. p < .05 was considered
signiﬁcant. Continuous variables are presented as means (standard
deviation (SD)).
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3. Results
3.1. VNS is a trigger for EADs and VT in LQTS
The eﬀects of combined cloﬂium-treatment and VNS on the in-
cidence of spontaneous EAD and VT in rabbit hearts are presented in
Fig. 1. Perfusion of cloﬁlium (100 nmol/L) caused a marked slowing of
intrinsic heart rate from 203 ± 33 to 164 ± 29 beats per minute
(p < .001) and prolongation of the QT interval (270 ± 34 vs.
177 ± 4ms, p < .001), but was not associated with spontaneous
ventricular arrhythmias. Meanwhile, EADs and TdP were readily trig-
gered by electrical stimulation of the vagus nerve in cloﬁlium treated
rabbit hearts. This can be seen in the representative trace in Fig. 1A,
showing a stimulation frequency-dependent slowing of heart rate and
the triggering of EADs with high intensity stimulation (20 Hz). VNS did
not induce ventricular arrhythmias in the absence of cloﬂium (data not
shown). Data presented on the left of Fig. 1B&C summarise the in-
cidence of arrhythmias with VNS in 11 experiments, and show that VNS
acted as a stimulation frequency-dependent trigger for spontaneous
EADs and VT in LQTS; with no arrhythmias observed in baseline con-
ditions (i.e. in hearts beating at their intrinsic rate). The percentage of
hearts exhibiting EADs increased from 0% at baseline to 73% with
20 Hz VNS, and the maximum incidence of spontaneous VT was 55%.
Neither EADs or spontaneous VT were observed with VNS before clo-
ﬁlium perfusion (data not shown). Arrhythmias were suppressed by the
restoration of normal beating rates, either spontaneously or by short-
term ventricular pacing (after which hearts returned to sinus rhythm)
(see Fig. 2). The pro-arrhythmic action of VNS is most likely attributed
to changes in rate, and not due to direct eﬀect on the ventricles, as VNS-
triggered EADs and VT were abolished by short term ventricular pacing
(~1min, Fig. 2). Furthermore, VNS mediated QT prolongation was
completely abolished by ventricular pacing (see Supplementary Fig. 1),
indicating that changes in rate are essential to the ventricular action of
the vagus nerve in the rabbit heart (data from untreated hearts).
3.2. T-wave duration and action potential triangulation predict EADs during
VNS
Table 1 presents a comparison of electrophysiological parameters in
hearts with and without spontaneous EADs during VNS (5 Hz) and
shows that the duration of the T-wave (TpTe interval), a measure of
ventricular dispersion of repolarisation, and triangulation of the ven-
tricular action potential, are the best predictors of VNS-associated
triggered activity. EADs were not predicted by the RR interval, QT in-
terval, APD and beat-to-beat variability in APD (as assessed from 10
sequential beats immediately before the ﬁrst EAD or the last 10-beats
before the cessation of VNS).
3.3. Sustained noradrenaline perfusion suppresses long QT associated
arrhythmias
In the presence of sustained (steady-state) noradrenaline, the pro-
pensity for EADs and VT with VNS was substantially reduced (Fig. 1B&
C). With VNS at 20 Hz, 73% of hearts exhibited EADs in control con-
ditions, compared to only 45% in the presence of noradrenaline. TdP
exhibited a similar pattern, with an incidence of 55% in control
Fig. 1. Sustained noradrenaline perfusion suppresses LQTS associated arrhythmias. A) Representative traces demonstrating the slowing of heart rate with increasing intensities of vagus
nerve stimulation (VNS) in a cloﬁlium-treated (100 nmol/L) rabbit heart. In this example, early afterdepolarisations (EADs) are triggered at 20 Hz VNS. B&C) Arrhythmias counts for 11-
experiments demonstrating a reduction in the incidence of EADs and ventricular tachycardia (VT) with sustained noradrenaline (NA, 100 nmol/L) perfusion. D&E) Individual and average
(Tukey's box plot) arrhythmias scores during VNS and with VNS+NA (sustained). Diﬀerent from VNS alone; *p < .05. Comparisons by Wilcoxon's matched-groups signed rank-sum test
(n=11 hearts).
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conditions vs. 27% during noradrenaline perfusion. The average ar-
rhythmias score, a measure of the severity of observed arrhythmias, was
reduced by sustained noradrenaline perfusion (Fig. 1D&E).
3.4. VNS antagonises the action of catecholamines on heart rate but not on
ventricular electrophysiology
The electrophysiological consequences of sustained (steady-state)
noradrenaline perfusion are presented in Fig. 3. As expected, nora-
drenaline perfusion resulted in an increase in heart rate and shortening
of the QT interval, as well as a reduction in the magnitude of action
potential triangulation. In the presence of noradrenaline, VNS slowed
heart rate to a greater degree than that observed in control conditions.
At baseline, and with low intensity VNS (2 Hz), heart rate was elevated
by noradrenaline, but this eﬀect was lost with at higher intensities of
stimulation (Fig. 3B) - showing that the vagus nerve antagonises the
action of noradrenaline on heart rate. By comparison, adrenergic-de-
pendent shortening of the QT interval was not reversed by VNS
(Fig. 3C). In fact, the magnitude of VNS-dependent QT prolongation
was less in the presence of catecholamines (68 ± 5ms vs.
127 ± 14ms, p= .003) and thus QT interval was substantially shorter
at all frequencies of nerve stimulation, despite a similar underlying
heart rate during high intensity VNS (see Fig. 3C). Similarly, a greater
increase in ventricular dispersion of repolarisation (as indicated by
prolongation of the TpTe interval) and triangulation of the action po-
tential was observed with VNS in the absence of adrenergic stimulation
(Fig. 3D&E). The TpTe interval increased by 136 ± 34% with VNS
alone and 64 ± 22% with VNS and noradrenaline perfusion
(p= .004). Action potential triangulation increased by 70 ± 16ms
with VNS in control conditions vs. 28 ± 9ms with VNS in the presence
noradrenaline (p= .003). Taken together, this suggests that VNS does
not antagonise the electrophysiological action of exogenous nora-
drenaline in the rabbit ventricle, whilst accentuated antagonism is
evident in changes in heart rate. This likely reﬂects the greater inﬂu-
ence of the parasympathetic nervous system at the sinoatrial node vs.
the ventricular myocardium. The anti-arrhythmic action of sustained
noradrenaline perfusion in LQTS may be attributed to the relative
shorter ventricular action potential and reduced action potential tri-
angulation during combined autonomic stimulation, which prevents
EADs. This action may be mediated by rate-dependent or rate-in-
dependent mechanisms, whereby the action potential intrinsically
shortens at faster beating rates (a consequence of the kinetic properties
of several ion channels and alterations in the concentration of in-
tracellular Ca and Na ions), and because of increased outward current
via the slow delayed rectifying K currents (via protein kinase A-de-
pendent phosphorylation of the channel subunits). Our data suggest
that rate-independent shortening of the ventricular action potential is
the major mechanism mediating the anti-arrhythmic action of sustained
noradrenaline perfusion, because with high intensity VNS there was no
diﬀerence* in heart rate between VNS alone and VNS plus noradrena-
line (Fig. 3B), but QT interval and APD were substantially shorter with
combined stimulation at all levels of VNS (Fig. 3C). [*A trend is ob-
served, possibly indicating a lack of statistical power to detect small
diﬀerences between groups.]
3.5. Bolus noradrenaline facilitates and exacerbates arrhythmias associated
with QT prolongation
Electrical pickup on the ECG recordings during direct sympathetic
nerve stimulation prevents accurate assessment of arrhythmias in the
isolated innervated rabbit heart. However, rapid infusion of nora-
drenaline appears to be a good correlate of sympathetic nerve stimu-
lation. Supplementary Fig. 2 shows the heart rate response to bolus
noradrenaline compared with moderate intensity bi-lateral sympathetic
nerve stimulation (10 Hz, 40 V, 2ms pulse duration). The presented
data show that the initial heart rate response to noradrenaline is mar-
ginally slower than that of direct nerve stimulation (owing to perfusion
delay), however, the maximum heart rate and time to peak heart rate
response was similar between conditions.
Data from 12 experiments on the inﬂuence of sudden adrenergic
stress on the incidence of LQTS associated arrhythmias are presented in
Fig. 4. Injection of a bolus of noradrenaline into the perfusion line acted
in a bi-phasic manner- ﬁrst increasing the risk of arrhythmias in the 10
to 20 second period immediately after injection and then acting to ac-
celerate the underlying heart rate, suppressing arrhythmic events. In
stage 1, bolus noradrenaline acted to increase the severity of the
Fig. 2. Suppression of VNS triggered arrhythmias by rapid pacing. Representative traces
showing spontaneous episodes of early afterdepolarisations and ventricular tachycardia
following vagus nerve stimulation (VNS), with subsequent rapid ventricular pacing (cycle
length=190ms) and on the cessation of pacing (following 1-min of sustained pacing).
Table 1
Electrophysiological predictors of early afterdepolarisations.
Parameters Experiments without
EADs
Experiments with
EADs
p-value
RR interval (ms) 465 (98) 560 (105) 0.139
QT Interval (ms) 335 (38) 382 (50) 0.098
TpTe Interval (ms) 59 (10) 99 (21) *0.001
APD90 (ms) 261 (26) 285 (42) 0.176
APD BBV (ms) 2.8 (3.9) 12.3 (24.0) 0.364
Action potential
triangulation (ms)
125 (17) 164 (39) *0.045
Comparison of electrocardiogram and monophasic action potential parameters in hearts
with and without early afterdepolarisations (EADs) during vagus nerve stimulation (VNS)
at 5 Hz. 10-beat averages immediately before the ﬁrst EAD or the last 10-beats before the
cessation of VNS. BBV=beat-to-beat variability. Data represent means (SD).
Comparisons by unpaired Student's t-tests. *p < .05 (n=6 per group).
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observed arrhythmias, with a dependence on the underlying conditions.
For instance, noradrenaline commonly triggered EADs in the absence of
pre-existing arrhythmias or caused VT in hearts already exhibiting ec-
topic activity. As such, VT was more commonly observed with nora-
drenaline perfusion during high intensities of VNS. In two of twelve
hearts, bolus noradrenaline led to periods of sustained VT (> 20 s),
which in one case degenerated into ventricular ﬁbrillation (VF). The
incidence of spontaneous EADs, VT and sustained VT/VF with VNS and
VNS plus bolus noradrenaline are presented in Fig. 4B–D. 67% of hearts
exhibited spontaneous VT with VNS+bolus noradrenaline vs. 33%
with VNS alone. Spontaneous EADs were observed in just 1 heart fol-
lowing noradrenaline perfusion in the absence of VNS. The severity of
arrhythmic events was increased by combined stimulation, over VNS
alone, as evidenced by an increase in the average arrhythmias score
(Fig. 4E&F).
3.6. Bolus noradrenaline causes a transient increase in action potential
duration and triangulation
To investigate the impact of sudden adrenergic stress on ventricular
electrophysiology in LQTS we analysed changes in electrophysiological
parameters following the injection of a bolus of noradrenaline in
baseline conditions (i.e. in the absence of VNS). This was necessitated
by the high incidence of arrhythmias during combined autonomic sti-
mulation. These data are presented in Fig. 5. Bolus noradrenaline
caused a rapid increase in heart rate that recovered to baseline over a
10-minute period (Fig. 5A). A transient increase in the duration of the
QT interval, ventricular MAPD90 and magnitude of action potential
triangulation was observed within approximately 10-s of noradrenaline
injection; followed by a sustained shortening of ventricular repolar-
isation and reduction of action potential triangulation (Fig. 5B–D). This
suggests that application of sudden adrenergic stress in LQTS leads to
transient pro-arrhythmogenic alterations in ventricular electro-
physiology. Indeed, the time course of changes in ventricular repolar-
isation paralleled the increase in the risk of arrhythmic events im-
mediately following noradrenaline perfusion (during VNS), as well as
the suppression of said arrhythmias with sustained adrenergic activa-
tion. Dispersion of repolarisation, as assessed from the duration of the
TpTe interval, was similar at all time points (Fig. 5E). No overall dif-
ference in beat-to-beat variability for QT interval or APD was observed
at any time point (data not shown).
4. Discussion
To our knowledge, this is the ﬁrst study to show the importance of
dynamic interplay between the two branches of the autonomic nervous
Fig. 3. Electrophysiological changes during VNS with and without sustained noradrenaline. A) Representative traces demonstrating changes in electrocardiogram (ECG) parameters
during VNS in a cloﬁlium-treated (100 nmol/L) rabbit heart, with and without sustained noradrenaline (NA, 100 nmol/L) perfusion. B–E) Average values on the change in heart rate, QT
interval, T-wave peak to end interval (TpTe) and monophasic action potential (MAP) triangulation. Data represent mean (SD). Diﬀerent from cloﬁlium (control); *p < .05. Two-way
repeated measures ANOVA, with Sidak's post-hoc tests (n=7 hearts).
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system in LQTS-associated arrhythmogenesis. Our results show that
combined adrenergic and parasympathetic stimulation has a complex
relationship with arrhythmogenicity in LQTS. Whilst sustained (steady-
state) noradrenaline perfusion suppresses the pro-arrhythmic action of
VNS, application of a sudden adrenergic stressor during a period of
sustained parasympathetic activation acts to increase the severity of
observed arrhythmias. Noradrenaline rarely triggers spontaneous VT
(1/12 hearts) in the absence of VNS, suggesting that concomitant au-
tonomic activation (or ‘autonomic conﬂict’) is required for the adre-
nergic facilitation of LQTS-associated arrhythmias. Importantly, this
observation parallels the clinical proﬁle for patients with congenital
LQTS type 2, who commonly die when woken suddenly by an alarm
clock - suggesting that they experience lethal arrhythmias when a surge
in sympathetic/adrenergic activity is superimposed during a time of
high parasympathetic tone (i.e. during rest or sleep) [10,13]. By re-
capitulating LQTS type II using drugs that block IKr, we show that the
number and severity of arrhythmias observed with VNS alone is ex-
acerbated by application of adrenergic stressor during sustained para-
sympathetic stimulation. Thus, the facilitation of arrhythmogenesis in
LQTS by adrenergic stress is critically dependent upon the timing and
sequence of autonomic stimulation. This dependence on the sequence
of events likely contributes to the stochastic nature of arrhythmias and
the diﬃculties in predicting any individual's risk of sudden death or the
timing of that death.
Most of studies on the inﬂuence on adrenergic activation on cardiac
electrophysiology have focussed on steady-state responses and there
has been only limited investigation into the importance of dynamic
changes in autonomic tone in LQTS. In studies in the isolated ven-
tricular wedge preparation, Schimizu et al. reported that in LQTS type
2, noradrenaline perfusion leads to a transient increase in transmural
dispersion of repolarisation [16]. The authors showed that increased
repolarisation heterogeneity correlated with an increase in the sus-
ceptibility to spontaneous and electrically induced VT. In our analysis
of T-wave duration we found no evidence that adrenergic stress results
in an increase in dispersion of repolarisation in the rabbit ventricles, but
observed a transient increase in action potential duration and triangu-
lation. The rate of repolarisation is thought to be an important factor in
the generation of EADs, as this may lead to the reactivation of the
Fig. 4. Bolus noradrenaline facilitates LQTS associated arrhythmias. A) Representative episodes of spontaneous ventricular tachycardia (VT) in a cloﬁlium-treated (100 nmol/L) rabbit
heart. The left trace was observed during VNS and the right following bolus noradrenaline (NA) perfusion (0.1mL of 1mM stock), in separate experiments. B-D) Arrhythmias counts for
12-experiments, demonstrating an increase in the incidence of early aftedepolarizations (EADs), VT and sustained VT (VTsus)/ventricular ﬁbrillation (VF) with VNS+NA (bolus). E&F)
Individual and average arrhythmias scores during VNS and with VNS+NA (bolus). Diﬀerent from VNS alone; *p < .05. Comparisons by Wilcoxon's matched-groups signed rank-sum
test (n=12 hearts).
J. Winter et al. Journal of Molecular and Cellular Cardiology 116 (2018) 145–154
150
inward calcium current and the reversal of membrane potential - either
directly via inward current through the L-type calcium channels or due
to stimulated release of calcium from the sarcoplasmic reticulum
[17–19]. Thus, the increase in action potential triangulation with
sudden adrenergic stress combined with parasympathetic activation
may facilitate EADs and explain the transient increase in risk of ar-
rhythmias with concomitant autonomic stimulation. Notably, recurrent
ectopic activity is one mechanism thought to underpin TdP and is a
feasible mechanism for the increased incidence of VT observed during
bolus noradrenaline injections [20]. Our observations parallel a report
by Liu et al., who demonstrated a transient risk for EADs in isolated
myocytes from rabbits with congenital LQTS type 2 on exposure to
isoprenaline - attributed to diﬀerential kinetics for activation of the L-
type calcium current and slow component of the delayed rectifying
potassium current [21]. A similar kinetic mismatch in the targets for
protein kinase A dependent phosphorylation was predicted by in-
tegrated computational modelling of calcium and beta-adrenergic sig-
nalling [22]. Interestingly, in a follow up study, Xie et al. predicted that
that sudden adrenergic stress favours the transition from VT to VF, due
to dynamic changes in APD restitution, which may have relevance to
our observation that bolus noradrenaline is associated with a transient
risk of more severe tachyarrhythmia [23]. Faster onset kinetics of the L-
type calcium current may explain the transient increase in action po-
tential duration, triangulation and incidence of VT with bolus nora-
drenaline perfusion in our study. With more sustained adrenergic sti-
mulation, the current carried by IKs is increased, acting to shorten the
action potential and to reduce the risk of further ectopic activity. The
same mechanism could explain why sustained adrenergic stimulation
Fig. 5. Electrophysiological eﬀects of bolus noradrenaline in LQTS. A) Experimental trace demonstrating the change in heart rate and monophasic action potential duration (MAPD90)
following bolus noradrenaline (NA) perfusion (0.1mL of 1mM stock) in a cloﬁlium treated (100 nmol/L) rabbit heart. A transient increase in MAPD90 is seen immediately following NA
perfusion. The inset shows representative action potentials recorded at the times indicated on the MAPD90 trace. B–E) Average values for QT interval, T-wave peak to end interval (TpTe),
MAPD90 and action potential triangulation at baseline, at peak response and at 30-second post-peak response. Data represent mean (SD). Diﬀerent from baseline; *p < .05. Comparisons
by one-way ANOVA, with Sidak's post-hoc tests (n=9 hearts).
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acts to suppress arrhythmias. Indeed, loss-of-function mutations in the
pore-forming subunits of channels that conduct IKs are the most
common form of congenital LQTS. In this scenario, IKs is weaker and
does not counteract the increase in L-type current during adrenergic-
stimulation, promoting EADs. Another factor in the suppression of
LQTS-associated arrhythmias by sustained adrenergic stimulation is the
resulting acceleration of heart rate, which shortens the action potential,
secondary to changes in the concentration of intracellular ions, in-
cluding, Na and Ca. Bradycardia is a well-established trigger for drug-
induced LQTS-related arrhythmias and tachypacing can prevent sudden
death both acutely and as a long-term therapy [24,25].
That VNS is an independent trigger for arrhythmias in drug-induced
LQTS is not surprising and is in keeping with existing clinical and ex-
perimental evidence. Bradycardia is a well-established risk factor for
TdP and Farkas et al. previously demonstrated that the induction of TdP
in the phenylephrine-sensitised rabbit is dependent upon activation of
the parasympathetic nervous system [26]. Phenylephrine, a selective
alpha1-adrenoceptor agonist, increases blood pressure and activates the
baroreceptor reﬂex, leading to a slowing of heart rate via the vagus
nerve. In our study, VNS causes prolongation and triangulation of the
ventricular action potential, which likely underpins the pro-ar-
rhythmogenic action of parasympathetic activation in LQTS. It is no-
table that one of the best correlates of ectopic activity following VNS
was the TpTe interval, a measure of dispersion of repolarisation. This
observation could indicate the requirement for a critical gradient of
repolarisation in order that ectopic beats can propagate through the
ventricular myocardium. Alternatively, the TpTe interval may simply
reﬂect the development of islands of tissue with prolonged APD from
where ectopic activity ﬁrst arises [27]. Furthermore, increased disper-
sion of repolarisation is a substrate that favours re-entrant arrhythmias
and may predispose to TdP, in keeping with our previous observations
[28].
Beta-adrenoceptor antagonists are the ﬁrst line therapy for con-
genital LQTS, with an eﬃcacy that is determined by the molecular basis
of QT-prolongation. Beta-adrenoceptor blockade is reported to be most
eﬀective in LQTS type 1 and only moderately eﬀective in LQTS type 2
and LQTS type 3 [10]. On this basis, we propose that the partial ef-
fectiveness of beta-blockade in congenital LQTS type 2 reﬂects that
arrhythmias can be triggered by parasympathetic activation alone, but
that the incidence and severity of arrhythmias is increased by sudden
adrenergic stress. Beta-blockade likely inhibits the latter case, but
clearly this does not entirely abolish the risk of TdP in this patient
population. Many useful therapeutic drugs, including antipsychotics
and antiarrhythmics, also cause QT prolongation and carry risk of TdP
and sudden cardiac death [29]. Where the risk-to-beneﬁt ratio is high,
QT-prolonging drugs should be withdrawn in patients exhibiting ex-
cessive QT prolongation or symptoms of LQTS (e.g. dizziness, syncope).
However, when the risk to beneﬁt ratio is low (i.e. low-risk, high-
beneﬁt), our data suggest that patients could beneﬁt from prophylactic
beta-adrenoceptor blockade. That is to say, beta-blockade may be an
eﬀective strategy to mitigate risk of sudden death in drug-induced
LQTS, in addition to congenital forms, and where there is no alternative
to use of QT-prolonging drugs. Symptoms of syncope and the risk of
sudden death in patients with congenital LQTS who are refractory to
beta-blockade can also be mitigated by left sympathetic denervation, a
surgical procedure that involves ablation of left stellate ganglion; the
major source of sympathetic eﬀerent nerve ﬁbers that innervate the
ventricles. Schwartz et al. have previously shown the eﬃcacy of this
approach in patients with congenital LQTS who continue with symp-
toms of syncope or cardiac arrest despite beta-blocker therapy [30].
With type 2 LQTS, where bradycardia is an independent trigger for
arrhythmias, further beneﬁts could be provided by the combined use of
beta-blockers/denervation and chronic atrial pacing [25].
We have previously suggested that autonomic conﬂict, the si-
multaneous activation of the sympathetic and parasympathetic inputs
to the heart, might be an arrhythmogenic trigger [3]. The basis for this
is observations of substantive cardiac dysrhythmia and arrhythmias in
young healthy adults within the ﬁrst minute of submersion in cold-
water; a potent stimulator of the sympathetically driven cold-water
shock response and parasympathetcally mediated mammalian diving
reﬂex. Importantly, similar events are not commonly observed in the
same participants during head out cold-water immersion, or with facial
immersion alone, suggesting that autonomic co-activation plays a cri-
tical role. We recently reported that combined autonomic stimulation
(i.e. sustained noradrenaline+VNS) is insuﬃcient to cause signiﬁcant
arrhythmias in healthy isolated rabbit hearts [31]. However, we show
presently that concomitant stimulation can trigger severe arrhythmias
in the presence of a predisposing electrophysiological abnormality, and
in a manner, that is critically dependent on the timing of the adrenergic
stimulus. Autonomic conﬂict may also have broader importance in
other forms of LQTS, for example, it may explain why swimming is a
gene-speciﬁc trigger for TdP and sudden death in congenital LQTS type
1 [9]. Moreover, dynamic events, leading to sudden alterations in au-
tonomic tone, are likely to be an important contributing factor in many
arrhythmogenic syndromes and pre-disposing conditions. For example,
swimming may be a trigger for arrhythmias in patients with genetic
mutations associated with catecholinergic polymorphic ventricular ta-
chycardia [11]. Greater understanding of how the dynamic changes in
autonomic tone inﬂuence electrophysiology and arrhythmogensis in
disease may be an important factor in the development of more eﬀec-
tive therapeutic strategies for the management of sudden cardiac death.
Animal models of TdP are essential for studies of the ar-
rhythmogenic processes in LQTS, and also have utility for safety
screening of QT prolonging drugs, however, there are several limita-
tions with existing experimental approaches. These include: the ne-
cessary use of anaesthetic agents in in vivo models [26], a failure to
predict the pro-arrhythmic potential of recognised torsadegenic drugs
[26], use of non-physiological conditions (e.g. perfusion of acetylcho-
line to mimic VNS), a reliance on expensive protocols (e.g. chronic
atrioventricular block in the dog) [32], and the low incidence of TdP in
the absence of electrical induction protocols [16]. In this study, we
describe a novel protocol that recapitulates LQTS-associated ar-
rhythmogenesis, including spontaneous EADs and VT. With con-
comitant autonomic stimulation (VNS+bolus noradrenaline) the
maximum incidence of EADs and VT in our study was 92% and 67%,
respectively. As such, the innervated rabbit heart may be a useful model
for the study of LQTS-associated arrhythmias. This approach has several
potential advantages over existing models, including; the preservation
of natural cardiac activation and repolarisation patterns, the ability to
perform repeat measurements in the same heart, no requirement for
anaesthetic agents, that heart rate can be altered physiologically by
direct nerve stimulation and great ﬂexibility/adaptability (e.g. rapid
washout of drugs, altered ionic composition). Moreover, the model is
relatively low-cost and requires only minimal training to implement.
This facility of the ex vivo innervated heart in drug safety screening will
require extensive validation and is a focus for future work.
4.1. Limitations
There are several limitations that deserve discussion. Firstly, in
preliminary experiments we found that direct sympathetic nerve sti-
mulation caused signiﬁcant electrical pickup on ECG recordings,
making it diﬃcult to accurately determine the onset and type of ar-
rhythmias. For this reason, we used exogenously perfused noradrena-
line to mimic the eﬀects of nerve stimulation. For the same reason, we
are unable to compare the electrophysiological responses to nora-
drenaline and SNS in our experimental model, and so cannot conclude
as to how similar bolus noradrenaline is to the traditional “ﬁght or
ﬂight” response, which is likely mediated by local neurotransmitter
release. Further studies, utilising techniques such as optical mapping,
which do not suﬀer from electrical interference, could be used to ad-
dress this limitation and to dissect out the underlying cellular
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mechanisms.
Secondly, both ketamine and medetomidine can inﬂuence auto-
nomic control. However, as experiments were performed in an in vitro
preparation, with signiﬁcant time for drug washout, we believe this is
unlikely to inﬂuence our results. Moreover, nerve responses were ro-
bust and reproducible throughout the experimental protocols.
Thirdly, the incidence of VT at baseline between protocols 1 and 2
was modestly diﬀerent (2 vs. 4 episodes), which could simply reﬂect
that more extended periods of VNS (as in protocol 1) are associated
with a higher incidence of spontaneous arrhythmias. However, given
that diﬀerence between the groups is not statistically signiﬁcant, this
observation may simply be down to chance.
Fourthly, on the slowing of heart rate with VNS, it was common for
map recordings to exhibit unstable diastolic potentials (when pre-
viously stable at baseline), which was likely attributed to slight
movement of the recording electrode secondary to altered contractile
motion of the heart. This can be seen in the example trace shown in
Fig. 1A. To avoid mechanical triggering of arrhythmias, we opted not to
re-orientate the electrode mid protocol. However, despite the observed
instability, it was still possible to accurately detect the onset of EADs,
particularly as our analysis relied on concomitant observations in MAP
recordings and in the ECG. Fifthly, we employed unilateral right-sided
VNS and so cannot conclude whether our ﬁndings also apply to left or
bilateral stimulation protocols. However, previous studies indicate that
there is no diﬀerence in the chronotropic and electrophysiological ef-
fects of left and right-sided VNS in pigs, which corroborates un-
published observations from our laboratory (in rabbits) [33].
Finally, cloﬁlium is a K channel blocker with a similar IC50 to E4031
and dofetilide, and has proven eﬃcacy for the induction of TdP in
rabbits [34]. The purpose of the present study was to develop a model
that replicates congenital LQTS and not necessarily to compare directly
to clinically used (or historical) pharmaceutical agents (e.g. D-sotalol,
dofetilide). Whilst alternative class III agents are more commonly em-
ployed in experimental studies, many K channel blockers exhibit similar
potency and we do not believe that our use of cloﬁlium detracts from
the conclusions of the present study [34]. Moreover, we have pre-
viously shown that VNS can trigger TdP in rabbit hearts treated with
E4031, a result replicated presently with cloﬁlium [28].
5. Conclusions
Autonomic conﬂict, the simultaneous activation of parasympathetic
and sympathetic autonomic inputs to the heart, can facilitate ar-
rhythmogenesis in LQTS. Dynamic alterations in autonomic tone may be
an important contributory factor in many arrhythmogenic syndromes
or in conditions that predispose to ventricular arrhythmias.
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